The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s anemia and other blood disorder drugs market report forecasts the anemia and other blood disorder drugs market size to grow to $14.80 Billion by 2027, with a CAGR (compound annual growth rate) of more than 5%.

Learn More On The Anemia And Other Blood Disorder Drugs Market Report 2023 – https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

Anemia And Other Blood Disorder Drugs Market Size Forecast
The global anemia and other blood disorder drugs market is expected to grow from $11.14 billion in 2022 to $11.87 billion in 2023 at a compound annual growth rate (CAGR) of 6.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global anemia and other blood disorder drugs market size is expected to grow to $14.80 billion in 2027 at a CAGR of 5.7%.

North America held the largest anemia and other blood disorder drugs market share, and Middle East was the fastest-growing region in 2022.

Key Anemia And Other Blood Disorder Drugs Market Driver ­– Increase In The Prevalence Of Anemia Among The Global Population Acts As A Strong
For instance, anemia was found to be the most frequent disease in the elderly population (> 65 years of age), reaching a prevalence rate of around 17%. the World Bank reported that anemia is the 8th leading cause of disease among women and the young population. Growth in the prevalence rate of anemia drives the market.

Request for A Sample Of The Global Anemia And Other Blood Disorder Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2465&type=smp

Key Anemia And Other Blood Disorder Drugs Market Trend – Collaborating With Other Companies To Develop
Companies in the anemia and other blood disorder drugs market are collaborating with other companies to develop and commercialize a specific kind of drug by sharing the knowledge, technology, and cost. Such collaborations are also helpful to the companies in case of expiring licenses and a stringent regulatory environment. For example, in 2020, Akebia Therapeutics announced collaboration with Tobacco Inc. to treat adult patients with iron deficiency anemia. Another such example is, Akebia Therapeutics Inc. and Otsuka Pharmaceutical Co. Ltd. agreed to manufacture and commercialize vadadustat, an oral HIF stabilizer, used for the treatment of anemia.

Anemia And Other Blood Disorder Drugs Market Segment
1) By Type: Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia
2) By Distribution Channel: Hospitals Pharmacy, Online Pharmacy, Pharmacy
3) By Route of Administration: Oral, Injectable
4) By Anemia Type : Microcytic (Low MCV), Normocytic (Normal MCV), Macrocytic (High MCV)

Anemia And Other Blood Disorder Drugs Market Major Players and Strategies
Major players in the anemia and other blood disorder drugs market are Amgen Inc., GlaxoSmithKline PLC., Akebia Therapeutics, Bayer AG, Pfizer Inc., Regenbiopharma, Hoffmann-La Roche Ltd., Merck Sharp &Dohme Corp., Novartis AG and Janssen Pharmaceutical.

In October 2022, Pfizer, a US-based pharmaceutical company acquired Global Blood Therapeutics Inc. for an undisclosed amount. Through this acquisition, Pfizer expanded its portfolio in the development of drugs and brought various potential best-in-class treatments to people living with sickle cell disease. Global Blood Therapeutics Inc. is a US-based biotech company operating in anemia and other blood disorder drugs.

The Anemia And Other Blood Disorder Drugs Global Market Report 2023 covers regional data on anemia and other blood disorder drugs market size, anemia and other blood disorder drugs market trends and drivers, opportunities, strategies, and anemia and other blood disorder drugs market competitor analysis. The countries covered in the anemia and other blood disorder drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Anemia and Other Blood Disorder Drugs refer to the medications or drugs that are used to treat anemia and other blood disorder diseases. It refers to a blood condition that develops when a medication prompts the body’s immune system to begin attacking its own red blood cells. Hemolysis, a process that causes red blood cells to degrade earlier than usual, is brought on by this.

View More Reports Related To The Anemia And Other Blood Disorder Drugs Market –
Blood Transfusion Diagnostics Global Market Report 2023
Blood Cancer Drugs Global Market Report 2023
Blood Glucose Meters Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: